中国快讯 (China Crunch) 为中国读者提供及时的加密新闻、市场洞察和监管动态。
DeepSeek AI funding: Tencent and CATL near US$7b
DeepSeek AI funding talks reportedly near a first US$7b round with Tencent and CATL, reshaping China’s model race, valuation benchmarks, and API growth.
Akeso lung cancer drug trial boosts hopes for US$20b market
Akeso lung cancer drug trial results are cautiously boosting optimism for a US$20b market as investors track data quality, timelines, and next regulatory steps.
Chinese Capital Floods Europe Tech in 2025 Surge
Chinese investment in Europe is hitting a 7 year high as Chinese buyers chase tech assets amid China-EU trade friction, with tighter screening and deal shifts.
CUHK launches humanoid lab to advance robotics
Hong Kong robotics lab at CUHK targets humanoid systems, new industry ties, and talent training, with research goals framed for near-term deployment.
China arrests 16 over drone hacking, Clean Skies
China drone hacking cases: China says 16 suspects were arrested as authorities expand the Clean Skies campaign and tighten drone regulation nationwide.
Hong Kong Tests GLP-1 Drugs for Stroke Recovery
Hong Kong teams are testing GLP-1 weight-loss drugs for stroke treatment, tracking neurological recovery signals, trial design, and market impact today.
DeepSeek nears $50b round, reshaping China AI
DeepSeek is nearing a first external round at a US$50 billion valuation, a defining moment for China AI startups as investors chase scale and defensibility.
US Nears $400 Million TikTok Privacy Settlement
The tiktok data privacy settlement nears US$400 million as US states weigh child privacy violations and a TikTok privacy settlement with strict compliance.
Tongji University disciplines cancer researcher Wang
China biotech faces scrutiny after Tongji University disciplined cancer researcher Wang Ping for academic misconduct, prompting calls for tighter oversight.
Moonshot AI at $20B as China IPO rules shift
Chinese AI startups face fresh scrutiny as Moonshot AI hits a $20B mark and adjusts IPO rules strategy, with investors watching timing and compliance.
Advertisement
